Abstract
This article describes a semi-industrial method for the production of formalinized poliomyelitis vaccine developed during 1956. The general technique followed that originally devised by Salk with modifications developed locally. The vaccine was tested for safety and innocuity according to the Minimum Requirements laid down by the United States Public Health Service. Seitz filtration was found to be essential for the production of a non-infectious vaccine; filtration through glass filters proved to give inconsistent results. High initial virus titres, proper filtration methods, and the use of a sensitive tissue-culture system for safety testing were considered to be of prime importance for the production of a safe and effective vaccine. Over 60 000 infants and young children were inoculated with this vaccine in a country-wide immunization programme during the winter and spring of 1957. No untoward effects were noted; an immunological evaluation of its performance in those inoculated is in progress.
Full text
PDF






















Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BROWN G. C., SMITH D. C. Serologic response of infants and preschool children to poliomyelitis vaccine. J Am Med Assoc. 1956 Jun 2;161(5):399–403. doi: 10.1001/jama.1956.02970050001001. [DOI] [PubMed] [Google Scholar]
- GARD S., LYCKE E., OLIN G., WESSLEN T. Inactivation of poliomyelitis virus by formaldehyde. Arch Gesamte Virusforsch. 1957;7(2):125–135. doi: 10.1007/BF01241813. [DOI] [PubMed] [Google Scholar]
- GARD S., WESSLEN T., FAGRAEUS A., SVEDMYR A., OLIN G. The use of guinea pigs in tests for immunogenic capacity of poliomyelitis virus preparations. Arch Gesamte Virusforsch. 1956;6(5):401–411. doi: 10.1007/BF01245926. [DOI] [PubMed] [Google Scholar]
- HOOK A. E., KUPSKY C. H., MCLEAN I. W., Jr, TIMM E. A. The nature of the formalin inactivation of poliomyelitis virus. J Immunol. 1956 Dec;77(6):444–452. [PubMed] [Google Scholar]
- RAPPAPORT C. Trypsinization of monkey-kidney tissue: an automatic method for the preparation of cell suspensions. Bull World Health Organ. 1956;14(1):147–166. [PMC free article] [PubMed] [Google Scholar]
- SALK J. E. Considerations in the preparation and use of poliomyelitis virus vaccine. J Am Med Assoc. 1955 Aug 6;158(14):1239–1248. doi: 10.1001/jama.1955.02960140001001. [DOI] [PubMed] [Google Scholar]
- SALK J. E., YOUNGNER J. S., WARD E. N. Use of color change of phenol red as the indicator in titrating poliomyelitis virus or its antibody in a tissue-culture system. Am J Hyg. 1954 Sep;60(2):214–230. doi: 10.1093/oxfordjournals.aje.a119714. [DOI] [PubMed] [Google Scholar]
- SCHEELE L. A., SHANNON J. A. Public health implications in a program of vaccination against poliomyelitis. J Am Med Assoc. 1955 Aug 6;158(14):1249–1258. doi: 10.1001/jama.1955.02960140011002. [DOI] [PubMed] [Google Scholar]
- SYVERTON J. T., BRUNNER K. T., TOBIN J. O., COHEN M. M. Recovery of viable virus from poliomyelitis vaccine by use of monkeys pretreated with cortisone and x-radiation. Am J Hyg. 1956 Jul;64(1):74–84. doi: 10.1093/oxfordjournals.aje.a119826. [DOI] [PubMed] [Google Scholar]
- VON MAGNUS H., VON MAGNUS P., PETERSEN I., GODTFREDSEN A., RONKJAER M. Polio vaccination in Denmark in April-June 1955. I. The production of formalinized poliovaccine and preliminary results. Dan Med Bull. 1955 Dec;2(8):226–233. [PubMed] [Google Scholar]
- YEKUTIEL P., LEVINGER E. L., MUHSAM H. V., YEKUTIEL M. P. Poliomyelitis outbreak in Israel, 1950-1. Bull World Health Organ. 1955;12(4):651–676. [PMC free article] [PubMed] [Google Scholar]
- ZITCER E. M., FOGH J., DUNNEBACKE T. H. Human amnion cells for large-scale production of polio virus. Science. 1955 Jul 1;122(3157):30–30. doi: 10.1126/science.122.3157.30. [DOI] [PubMed] [Google Scholar]